Cheongju-si, South Korea

Young Kim

This inventor holds 1 USPTO granted patent. Top assignee: E&S Healthcare Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Kim. Retrieved from https://idiyas.com/inventor/young-kim-rmlydz3r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Kim: Innovator in Breast Cancer Diagnosis

Introduction

Young Kim is a notable inventor based in Cheongju-si, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in breast cancer detection. His innovative work has the potential to improve patient outcomes and enhance diagnostic accuracy.

Latest Patents

Young Kim holds a patent for a "Monoclonal Antibody Specifically Binding to Thioredoxin 1 and Methods of Use Thereof for Breast Cancer Diagnosis." This patent represents a crucial advancement in the development of targeted therapies and diagnostic tools for breast cancer.

Career Highlights

Throughout his career, Young Kim has been associated with E&S Healthcare Co., Ltd., where he has focused on research and development in healthcare technologies. His work has garnered attention for its potential impact on cancer diagnostics.

Collaborations

Young Kim has collaborated with notable colleagues, including Kyong Hoon Suh and Dae Joong Kim. These partnerships have fostered innovation and contributed to the advancement of medical research.

Conclusion

Young Kim's contributions to breast cancer diagnosis through his patented innovations highlight his role as a key figure in medical research. His work continues to pave the way for advancements in healthcare technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…